The Will Rogers phenomenon, Breast Cancer and Race

Autor: Eswar K. Mundra, Mary R Nittala, Shawn McKinney, Divyang Mehta, Srinivasan Vijayakumar, William C. Woods, Maria L. Smith, Barbara S. Craft, Satyaseelan Packianathan
Rok vydání: 2020
Předmět:
Oncology
Cancer Research
Kaplan-Meier Estimate
Tumor grade
0302 clinical medicine
Mississippi
Breast cancer
Surgical oncology
030212 general & internal medicine
Breast
Racial disparities
RC254-282
Aged
80 and over

Academic Medical Centers
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Middle Aged
Prognosis
Survival Rate
030220 oncology & carcinogenesis
Cohort
symbols
Female
Stage IIIa
Research Article
Adult
medicine.medical_specialty
Breast Neoplasms
Will Rogers phenomenon
Disease-Free Survival
White People
Stage ib
03 medical and health sciences
symbols.namesake
Internal medicine
Genetics
medicine
Humans
Aged
Neoplasm Staging
Retrospective Studies
business.industry
Proportional hazards model
Health Status Disparities
medicine.disease
Black or African American
Neoplasm Grading
business
Safety-net Providers
Follow-Up Studies
Zdroj: BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
DOI: 10.21203/rs.3.rs-48135/v1
Popis: Background The Will Rogers phenomenon [WRP] describes an apparent improvement in outcome for patients’ group due to tumor grade reclassification. Staging of cancers is important to select appropriate treatment and to estimate prognosis. The WRP has been described as one of the most important biases limiting the use of historical cohorts when comparing survival or treatment. The main purpose of this study is to assess whether the WRP exists with the move from the AJCC 7th to AJCC 8th edition in breast cancer [BC] staging, and if racial differences are manifested in the expression of the WRP. Methods This is a retrospective analysis of 300 BC women (2007–2017) at an academic medical center. Overall survival [OS] and disease-free survival [DFS] was estimated by Kaplan-Meier analysis. Bi and multi-variate Cox regression analyses was used to identify racial factors associated with outcomes. Results Our patient cohort included 30.3% Caucasians [Whites] and 69.7% African-Americans [Blacks]. Stages I, II, III, and IV were 46.2, 26.3, 23.1, and 4.4% of Whites; 28.7, 43.1, 24.4, and 3.8% of Blacks respectively, in anatomic staging (p = 0.043). In prognostic staging, 52.8, 18.7, 23, and 5.5% were Whites while 35, 17.2, 43.5, and 4.3% were Blacks, respectively (p = 0.011). A total of Whites (45.05% vs. 47.85%) Blacks, upstaged. Whites (16.49% vs. 14.35%) Blacks, downstaged. The remaining, 38.46 and 37.79% patients had their stages unchanged. With a median follow-up of 54 months, the Black patients showed better stage-by-stage 5-year OS rates using 8th edition compared to the 7th edition (p = 0.000). Among the Whites, those who were stage IIIA in the 7th but became stage IB in the 8th had a better prognosis than stages IIA and IIB in the 8th (p = 0.000). The 8th showed complex results (p = 0.176) compared to DFS estimated using the 7th edition (p = 0.004). Conclusion The WRP exists with significant variability in the move from the AJCC 7th to the 8th edition in BC staging (both White and Black patients). We suggest that caution needs to be exercised when results are compared across staging systems to account for the WRP in the interpretation of the data.
Databáze: OpenAIRE